Naproxen

4 trials MMusculoskeletal

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

4 Completed trials

5 Sponsors

11 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 1 Phase IV: 1

Oversight events:

2 temporary halts 2 urgent safety measures 1 corrective measure across 3 trials

View oversight register →

Indications tested

Axial spondyloarthritis 1 Gout 1 Endometriosis 1

Sponsors using this IMP

Apurano Pharmaceuticals GmbH 1 Cannaxan GmbH 1 Charite Universitaetsmedizin Berlin KöR 1 Chugai Pharmaceutical Co. Ltd. 1 LG Chem Ltd. 1

All trials

4 total

A study to evaluate the efficacy and safety of AMY109 in women with endometriosis Ended

2023-507289-14-00 Phase II 3 countries Chugai Pharmaceutical Co. Ltd.
A study to assess the efficacy and safety of tigulixostat at different doses as compared to a control drug (allopurinol) in gout patients wi… Ended

2022-501421-20-00 Phase III 9 countries LG Chem Ltd.
Tofacitinib in early active axial spondyloarthritis: a prospective, randomized, double-blind, placebo-controlled multicentre study - FASTLAN… Ended

2023-505050-18-00 Phase IV 4 countries Charite Universitaetsmedizin Berlin KöR
Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain Ended

2022-502151-54-00 Phase III 2 countries Apurano Pharmaceuticals GmbH; Cannaxan GmbH

Showing 1–4 of 4 trials

← All drugs A–Z